Abstract:Background: Ganoderma lucidum, which is widely used as “Ganoderma” in China or other Asian countries (Japan, Korea, etc), exerts an important role in tonifying qi and calming the mind in clinical applications. Triterpenoids are the main active components in Ganoderma lucidum, with significant biological activities of hepatoprotective, anticancer, and anti-tumor, etc. However, the current analysis of triterpenoids in Ganoderma lucidum by mass spectrometry is limited, restricting its quality control and elucidation of its functional basis. Objective: This work aimed to systematically characterize the triterpenoids in Ganoderma lucidum. Methods: The Ganoderma lucidum powder was extracted by 50% ethanol/water and separated by Waters ACQUITY UPLC HSS T3 column (2.1 mm×100 mm, 1.8 μm). The data was obtained by Waters G2-Q-TOF mass spectrometry equipped with an electrospray ionization ion (ESI) source, and the MS data under positive and negative modes was acquired and analyzed. Results: A total of 43 triterpenoids were identified or tentatively characterized from the extracts of Ganoderma lucidum, including 32 known compounds and 11 potential new compounds. Among them, five triterpenoids were unambiguously identified by comparison with reference standards, including ganoderic acid A(28), ganoderic acid D(36), ganoderenic acid D(34), ganoderic acid F(43), and ganoderic acid G(16). The profiled triterpenoids could be divided into eight types according to the substituents at the C3, C7 and C15 positions of the parent structure. The mass fragmentation rules of Ganoderma lucidum triterpenoids were summarized. Under the positive ion mode, Ganoderma lucidum triterpenoids easily lost CH3 at the C10 position and H2O at C3, C7, and C15 positions, and the side chain bond at the C22(23) position was easily split. Under the negative ion mode, the split of the C and D rings was the characteristic feature. result: A total of 43 triterpenoids were identified or tentatively characterized from the extracts of Ganoderma lucidum, including 32 known compounds and 11 potential new compounds. Among them, five triterpenoids were unambitiously identified by comparison with reference standards, including ganoderic acid A(28), ganoderic acid D(36), ganoderenic acid D(34), ganoderic acid F(43), and ganoderic acid G(16). These triterpenoids could be divided into eight types according to the substituents at the C3, C7 and C15 positions of the parent structure. The mass fragmentation rules of Ganoderma lucidum triterpenoids were summarized. Under the positive ion mode, Ganoderma lucidum triterpenoids easily lost CH3 at the C10 position and H2O at C3, C7, C15 position, and the side chain bond at C22(23) position was easily cracked. Under the negative ion mode, the crack of the C and D rings was the characteristic feature. Conclusion: The mass fragmentation behaviors of Ganoderma lucidum triterpenoids under positive ion mode were summarized and emphasized, and reliable scientific data and methods for systematic characterization of Ganoderma lucidum triterpenoids were also supplied.

Pharmacokinetic Studies of Ganoderic Acids from the Lingzhi or Reishi Medicinal Mushroom, Ganoderma Lucidum (agaricomycetes), by LC-MS/MS.

Composition Analysis And Immunomodulatory Capacity Of Peptidoglycan From Ling Zhi Or Reishi Medicinal Mushroom, Ganoderma Lucidum (W. Curt.: Fr.) P. Karst. Strain 119 (Aphyllophoromycetideae)

Triterpenes and Soluble Polysaccharide Changes in Lingzhi or Reishi Medicinal Mushroom, Ganoderma Lucidum (agaricomycetes), During Fruiting Growth

HPLC Method for the Determination and Pharmacokinetic Studies of Four Triterpenoids in Rat Plasma after Oral Administration of Ganoderma Lucidum Extract.

Systematic Characterization of Triterpenoids in Ganoderma lucidum by UHPLC-Q/TOF MS

Structural Identification of the Metabolites of Ganoderic Acid B from Ganoderma Lucidum in Rats Based on Liquid Chromatography Coupled with Electrospray Ionization Hybrid Ion Trap and Time-Of-Flight Mass Spectrometry

Structural Characterization of Minor Metabolites and Pharmacokinetics of Ganoderic Acid C2 in Rat Plasma by HPLC Coupled with Electrospray Ionization Tandem Mass Spectrometry

Influence of different cultivation methods on ganoderic acid synthesis and solid-state fermentation condition optimization

Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography.

Pharmacokinetics of ganoderic acid D and its main metabolite by liquid chromatography-tandem mass spectrometry.

Changes of Active Substances in Ganoderma lucidum during Different Growth Periods and Analysis of Their Molecular Mechanism

Determination of ganoderic acids in rat plasma after oral administration of total triterpenoids from Ganoderma lucidum

Ganoderma lucidum and its pharmaceutically active compounds

Optimization of ultrasonic-assisted extraction of polysaccharides and triterpenoids from the medicinal mushroom Ganoderma lucidum and evaluation of their in vitro antioxidant capacities

Rapid Determination of Diverse Ganoderic Acids in Ganoderma Using UPLC–MS/MS

Submerged Fermentation Production and Characterization of Intracellular Triterpenoids from Ganoderma Lucidum Using HPLC-ESI-MS.

Identification of metabolites of ganoderic acid D by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

Metabolite identification of crude extract from Ganoderma lucidum in rats using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry

Efficient Accumulation and in Vitro Antitumor Activities of Triterpene Acids from Submerged Batch-Cultured Lingzhi or Reishi Medicinal Mushroom, Ganoderma Lucidum (Agaricomycetes)

Neuropharmacological Effect and Clinical Applications of Ganoderma (Lingzhi).

Ganoderma lucidum: A Potent Pharmacological Macrofungus